In case there was any doubt that the drug price backlash is having little effect on the willingness of big pharma to pay top dollar for promising new drugs, the $624 million buyout of a Canadian biotech by Marlborough-based Sunovion Pharmaceuticals ought to make that fact clear. Sunovion, a privately held subsidiary of Japan-based Sumitomo Dainippon Pharma Co., announced late Wednesday that it plans to buy Toronto-based Cynapsus Therapeutics Inc.

BING NEWS:
  • Edmonton's luxury market offers top value in large Canadian cities
    Edmonton’s resale market has long been comparatively well-priced to other major real estate markets in Canada, and luxury is no exception, a new report shows. “If you look through the lens of other ...
    04/18/2024 - 4:26 am | View Link
  • 3 Cheap Canadian Stocks That Offer Over 7% Dividend Yields
    Considering their high-yielding dividends and attractive valuations, these three stocks can be excellent holdings right now. The post 3 Cheap Canadian Stocks That Offer Over 7% Dividend Yields ...
    04/16/2024 - 2:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News